Literature DB >> 16574947

Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis.

Jeanne-Claire Lesbordes-Brion1, Lydie Viatte, Myriam Bennoun, Dan-Qing Lou, Guillemette Ramey, Christophe Houbron, Ghislaine Hamard, Axel Kahn, Sophie Vaulont.   

Abstract

We previously reported that mice made deficient for the transcriptional factor USF2 fail to express hepcidin 1 and hepcidin 2 genes as a consequence of targeted disruption of the Usf2 gene lying just upstream in the locus. These mice developed an iron overload phenotype with excess iron deposition in parenchymal cells and decreased reticuloendothelial iron. At that time, although the role of USF2 was still confounding, we proposed for the first time the role of hepcidin as a negative regulator of iron absorption and iron release from macrophages. Accordingly, we subsequently demonstrated that hyperexpression of hepcidin 1, but not hepcidin 2, resulted in a profound hyposideremic anemia. To analyze the consequences of hepcidin 1 deletion on iron metabolism without any disturbance due to USF2 deficiency, we disrupted the hepcidin 1 gene by targeting almost all the coding region. Confirming our prior results, Hepc1(-/-) mice developed early and severe multivisceral iron overload, with sparing of the spleen macrophages, and demonstrated increased serum iron and ferritin levels as compared with their controls.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574947     DOI: 10.1182/blood-2006-02-003376

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  109 in total

1.  Investigation of the role of interleukin-6 and hepcidin antimicrobial peptide in the development of anemia with age.

Authors:  Bryan J McCranor; Jacqueline M Langdon; Olivier D Prince; Laurette K Femnou; Alan E Berger; Chris Cheadle; Curt I Civin; Airie Kim; Seth Rivera; Tomas Ganz; Sophie Vaulont; Qian-Li Xue; Jeremy D Walston; Cindy N Roy
Journal:  Haematologica       Date:  2013-08-30       Impact factor: 9.941

2.  Hepcidin Protects against Lethal Escherichia coli Sepsis in Mice Inoculated with Isolates from Septic Patients.

Authors:  Deborah Stefanova; Antoan Raychev; Jaime Deville; Romney Humphries; Shelley Campeau; Piotr Ruchala; Elizabeta Nemeth; Tomas Ganz; Yonca Bulut
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

Review 3.  Iron homeostasis and eye disease.

Authors:  Allison Loh; Majda Hadziahmetovic; Joshua L Dunaief
Journal:  Biochim Biophys Acta       Date:  2008-11-14

Review 4.  Forging a field: the golden age of iron biology.

Authors:  Nancy C Andrews
Journal:  Blood       Date:  2008-07-15       Impact factor: 22.113

5.  Lipopolysaccharides upregulate hepcidin in neuron via microglia and the IL-6/STAT3 signaling pathway.

Authors:  Zhong-Ming Qian; Xuan He; Tuo Liang; Ka-Chun Wu; Yik-Chun Yan; Li-Na Lu; Guang Yang; Qian Qian Luo; Wing-Ho Yung; Ya Ke
Journal:  Mol Neurobiol       Date:  2014-12       Impact factor: 5.590

Review 6.  Iron homeostasis: An anthropocentric perspective.

Authors:  Richard Coffey; Tomas Ganz
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

7.  Inductively coupled mass spectrometry analysis of biometals in conditional Hamp1 and Hamp1 and Hamp2 transgenic mouse models.

Authors:  S Lu; J Seravalli; D Harrison-Findik
Journal:  Transgenic Res       Date:  2015-04-23       Impact factor: 2.788

8.  Endogenous siderophore 2,5-dihydroxybenzoic acid deficiency promotes anemia and splenic iron overload in mice.

Authors:  Zhuoming Liu; Alieta Ciocea; L Devireddy
Journal:  Mol Cell Biol       Date:  2014-04-28       Impact factor: 4.272

9.  Hepcidin targets ferroportin for degradation in hepatocytes.

Authors:  Guillemette Ramey; Jean-Christophe Deschemin; Béatrice Durel; François Canonne-Hergaux; Gaël Nicolas; Sophie Vaulont
Journal:  Haematologica       Date:  2009-09-22       Impact factor: 9.941

10.  Hepcidin Is Essential for Alveolar Macrophage Function and Is Disrupted by Smoke in a Murine Chronic Obstructive Pulmonary Disease Model.

Authors:  Elizabeth Perez; Jonathan R Baker; Silvana Di Giandomenico; Pouneh Kermani; Jacqueline Parker; Kihwan Kim; Jianjun Yang; Peter J Barnes; Sophie Vaulont; Joseph M Scandura; Louise E Donnelly; Heather Stout-Delgado; Suzanne M Cloonan
Journal:  J Immunol       Date:  2020-09-21       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.